We are comparing the absorption of two similar OEA products.

Product A – Standard formulation: Contains only the active ingredient of interest. Using a standard product helps us to be confident that any effects we measure in the active group really are due to the active ingredient and not due to the body’s own reaction to a perceived treatment. 

Product B – Active formulation: Contains the same ingredient as the standard formulation, but with technology designed to aid absorption.

This study will be comparing how fast and how much OEA is absorbed over an seven hour period. During your participation you will be given all 2 products (2 weeks apart) and your results will be analysed and compared.

The products are in capsule form, and you would be required to take a single dose of 2 capsules, 2 weeks apart. If you have trouble swallowing tablets or capsules, this study may not be suitable for you.

As this study is assessing absorption, it is important that participants have not been taking OEA in the lead up to the study (1 month). This is to ensure that all participants have similar baseline (starting) levels.

 The study will involve approximately 15 men and women in a cross-over absorption study. This means that 15 people will first take Product A or Product B, and then the same 15 people will return 2 weeks later to take a second alternate product.

Your individual results from each Product A and B will be compared to the absorption of each other.

In order to measure absorption, several blood samples will be taken over the course of the study period. But do not worry about multiple ‘needle pricks’; a cannula will be placed in your arm at the start of each Day 1 visit.

A small amount of blood will be drawn at baseline and then regular draws taken throughout Day 1. The cannula will be removed at the end of Day 1 for you to return home.

You will then return to our clinic the following morning (Day 2) for a single blood draw (24 hours after baseline) via a needle.

 Study Program Dates:

Round 1

• • Thursday September 11th Day 1 : 7:30am to approximately 3:30pm
  • Friday September 12th Day 2 : Approximately 30 minutes (between 7 and 9am)

Round 2

• • Thursday September 25th Day 1 : 7:30am to approximately 3:30pm
  •  Friday September 26th Day 2 : Approximately 30 minutes (between 7 and 9am)

During each Day 1, while you are in attendance at our clinic, we will provide meals and snacks throughout the day

Our clinic is equipped with fast Wifi so we encourage you to bring your device / laptop with you to work, study or stream your favourite shows (headphones please!).

Please register your interest by answering the questionnaire and completing the form on this page…we’ll then get in touch to screen you for suitability.

• Aged over 18 years old
• Have no history of issues with blood draws or cannulation
• Able to swallow tablets/capsules
• A non-smoker
• BMI between 18.5-34.9
• Not currently taking OEA
• Generally healthy and free of any significant medical conditions
• Not taking any long term prescription medications
• Able to attend for an entire Study Program 

At the conclusion of your participation you will be eligible to receive a payment of up to $400. This will be transferred into your preferred bank account within 2 business days.

This study is being conducted in collaboration with The University of Queensland and has been approved by The University of Queensland Ethics Committee under Approval Number 2024/HE000071. The Principal Investigator is Dr David Briskey (PhD), Research Fellow (UQ).

As with all of our studies, data and results are all deidentified to ensure your privacy.

Participant Information and Consent Form (PICF)

Prior providing your consent to participate in this study you will receive a copy of the Participant Information and Consent Form (PICF). This document is approved by the ethics committee and contains further information about the study. Your written consent is required prior to your participation in this study.